Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population.

"Authors’ Disclosures or Potential Conflicts of Interest Upon manuscript submission, all authors completed the author disclosure form. Disclosures and/or potential conflicts of interest: Upon manuscript submission, all authors completed the author disclosure form. Disclosures and/or potential conflicts of interest:"

"Research Funding S.J.R. Meex, Abbott Diagnostics and Roche Diagnostics; N. Sattar, Boehringer Ingelheim; P. Welsh, Roche, Boehringer Ingelheim, Chief Scientist Office, Scotland, Astrazeneca, Novartis. Troponin measurements and analysis were supported by a Stratified Medicine Grant from the Chief Scientist Office of the Scottish Government Health Directorates (ASM/14/1). Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006). The study was supported by Health Data Research UK, which receives its funding from HDR UK Ltd (HDR-5012) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and the Wellcome Trust. D.M. Kimenai is supported by a Kootstra Talent Fellowship (19.1314). C. Hayward is supported by an MRC University Unit Programme Grant MC_UU_00007/10 (QTL in Health and Disease). N.L. Mills is supported by the British Heart Foundation through a Senior Clinical Research Fellowship (FS/16/14/32023), Programme Grant (RG/20/10/34966) and a Research Excellence Award (RE/18/5/34216). "